Variant report
Variant | nsv608958 |
---|---|
Chromosome Location | chr7:147279947-147282327 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr20:53098001..53098695-chr7:147280534..147281382,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10281966 | chr7:147279947-147279948 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs28563946 | chr7:147279955-147279956 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs182666216 | chr7:147279975-147279976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs112972199 | chr7:147279982-147279983 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs10226112 | chr7:147280000-147280001 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs559134170 | chr7:147280008-147280009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs528331287 | chr7:147280065-147280066 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs12056020 | chr7:147280071-147280072 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs571743857 | chr7:147280079-147280080 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185472595 | chr7:147280118-147280119 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs551015219 | chr7:147280148-147280149 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529880239 | chr7:147280164-147280165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs10226376 | chr7:147280197-147280198 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs190872240 | chr7:147280198-147280199 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs10226389 | chr7:147280237-147280238 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs77540070 | chr7:147280255-147280256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs10226499 | chr7:147280317-147280318 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs10226510 | chr7:147280337-147280338 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs10241611 | chr7:147280338-147280339 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs543085368 | chr7:147280371-147280372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10244825 | chr7:147280382-147280383 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs573263684 | chr7:147280387-147280388 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs183877531 | chr7:147280410-147280411 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140374341 | chr7:147280421-147280422 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145456978 | chr7:147280488-147280489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs114690783 | chr7:147280493-147280494 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs34920436 | chr7:147280552-147280553 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs28654757 | chr7:147280555-147280556 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs201574277 | chr7:147280596-147280597 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs73741413 | chr7:147280623-147280624 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs71183019 | chr7:147280624-147280625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs192930035 | chr7:147280649-147280650 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs34407140 | chr7:147280652-147280653 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10245208 | chr7:147280658-147280659 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
35 | rs10227024 | chr7:147280716-147280717 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
36 | rs10255433 | chr7:147280742-147280743 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
37 | rs150983393 | chr7:147280749-147280750 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs55843999 | chr7:147280766-147280767 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs112673086 | chr7:147280772-147280773 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs182994938 | chr7:147280776-147280777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs569306009 | chr7:147280799-147280800 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs187362037 | chr7:147280819-147280820 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs191854285 | chr7:147280863-147280864 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs573400894 | chr7:147280939-147280940 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs542244713 | chr7:147280952-147280953 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183846200 | chr7:147280967-147280968 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs141012687 | chr7:147280990-147280991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs189196172 | chr7:147280991-147280992 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs10230213 | chr7:147281034-147281035 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs78410201 | chr7:147281046-147281047 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Wilms tumour | 21544195 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Papillary thyroid carcinoma | 21436994 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 18496225 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Breast cancer | 16272173 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Stuttering | 21108403 | CNVD |
Breast cancer | 17603634 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Myelodysplastic syndrome | 17634407 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 17133270 | CNVD |
Schizophrenia | 17646849 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Heart disease | 21282601 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Pancreatitis | 21956041 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Gastric cancer | 16891809 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Cancer | 20164920 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Autism | 20808228 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Melanoma | 20877625 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21509527 | CNVD |
Autism | 20964600 | CNVD |
Epilepsy | 17646849 | CNVD |
Mental retardation | 19896112 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Ovarian cancer | 21720365 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:147268000-147283800 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr7:147278400-147283800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
3 | chr7:147280400-147282200 | Enhancers | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
4 | chr7:147280800-147282200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
5 | chr7:147281000-147282200 | Enhancers | H1 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
6 | chr7:147281000-147282400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
7 | chr7:147281000-147284400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr7:147281400-147282000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr7:147281400-147284800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
10 | chr7:147281400-147284800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
11 | chr7:147281600-147282400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr7:147281600-147284600 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr7:147281800-147282200 | Enhancers | H1 Cell Line | embryonic stem cell |
14 | chr7:147281800-147282200 | Enhancers | H9 Cell Line | embryonic stem cell |
15 | chr7:147281800-147282200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr7:147281800-147282200 | Enhancers | iPS DF 6.9 Cell Line | embryonic stem cell |
17 | chr7:147281800-147282200 | Enhancers | Gastric | stomach |
18 | chr7:147281800-147283000 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
19 | chr7:147282200-147283000 | Weak transcription | H1 Cell Line | embryonic stem cell |
20 | chr7:147282200-147283000 | Weak transcription | hESC Derived CD56+ Ectoderm Cultured Cells | ES cell derived |
21 | chr7:147282200-147283000 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
22 | chr7:147282200-147283600 | Weak transcription | H9 Cell Line | embryonic stem cell |
23 | chr7:147282200-147283600 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |